Raffaella Pippa

937 total citations
20 papers, 480 citations indexed

About

Raffaella Pippa is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raffaella Pippa has authored 20 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raffaella Pippa's work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Raffaella Pippa is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Raffaella Pippa collaborates with scholars based in Spain, United States and United Kingdom. Raffaella Pippa's co-authors include María D. Odero, Elena Arriazu, Dale J. Christensen, Michael P. Vitek, Jeffrey Tyner, Rosalie C. Sears, Anupriya Agarwal, Oriol Bachs, Brian Druker and Christopher A. Eide and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Raffaella Pippa

17 papers receiving 476 citations

Peers

Raffaella Pippa
Jessica Oddo United States
Srilatha Nalluri United States
Sourik S. Ganguly United States
Chee Man Cheong Australia
Natacha Bohin United States
Gina M. Ney United States
Jessica Oddo United States
Raffaella Pippa
Citations per year, relative to Raffaella Pippa Raffaella Pippa (= 1×) peers Jessica Oddo

Countries citing papers authored by Raffaella Pippa

Since Specialization
Citations

This map shows the geographic impact of Raffaella Pippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaella Pippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaella Pippa more than expected).

Fields of papers citing papers by Raffaella Pippa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaella Pippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaella Pippa. The network helps show where Raffaella Pippa may publish in the future.

Co-authorship network of co-authors of Raffaella Pippa

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaella Pippa. A scholar is included among the top collaborators of Raffaella Pippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaella Pippa. Raffaella Pippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McMillan, Elizabeth A., Carine Bossard, Carsten Merkwirth, et al.. (2022). Abstract 3928: The pan-CLK/DYRK inhibitor cirtuvivint selectively disrupts alternative splicing and has broad anti-tumor activity in preclinical models. Cancer Research. 82(12_Supplement). 3928–3928.
2.
Krishn, Shiv Ram, George G. Daaboul, Raffaella Pippa, et al.. (2020). Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells. Journal of Extracellular Vesicles. 9(1). 1761072–1761072. 32 indexed citations
3.
Arriazu, Elena, Carmen Vicente, Raffaella Pippa, et al.. (2020). A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia. Blood Cancer Journal. 10(1). 3–3. 28 indexed citations
4.
Pippa, Raffaella & María D. Odero. (2020). The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias. Cells. 9(3). 544–544. 25 indexed citations
5.
Woo, JungReem, Sandra Santasusagna, Kamlesh K. Yadav, et al.. (2020). Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer. The Journal of Urology. 204(4). 691–700. 15 indexed citations
6.
Vicente, Carmen, Elena Arriazu, Nerea Marcotegui, et al.. (2019). A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. Cancer Letters. 468. 1–13. 33 indexed citations
7.
Woo, JungReem, Sandra Santasusagna, Benjamin E. Leiby, et al.. (2019). GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 18–18. 3 indexed citations
8.
Pippa, Raffaella, Silvia Boffo, María D. Odero, & Antonio Giordano. (2019). Data mining analysis of the PP2A cell cycle axis in mesothelioma patients. Journal of Cellular Physiology. 235(6). 5284–5292. 5 indexed citations
9.
Endo, Akinori, Tony Ly, Raffaella Pippa, et al.. (2016). The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells. Journal of Biological Chemistry. 292(1). 172–184. 7 indexed citations
10.
Arriazu, Elena, Raffaella Pippa, & María D. Odero. (2016). Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia. Frontiers in Oncology. 6. 78–78. 44 indexed citations
11.
Pippa, Raffaella, Deanne Tibbitts, Dale J. Christensen, et al.. (2016). Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia. Oncotarget. 7(51). 84214–84227. 27 indexed citations
12.
Pippa, Raffaella, Ana Lucía Dominguez, Raquel Malumbres, et al.. (2016). MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia. Oncotarget. 8(33). 53989–54003. 26 indexed citations
13.
Laguna, Teresa, Raffaella Pippa, Berta N. Vázquez, et al.. (2015). New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2. Molecular Immunology. 66(2). 171–179. 12 indexed citations
14.
Agarwal, Anupriya, Raffaella Pippa, Christopher A. Eide, et al.. (2014). Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia. Clinical Cancer Research. 20(8). 2092–2103. 103 indexed citations
15.
Pippa, Raffaella & María D. Odero. (2014). Importance of genetics in acute myeloid leukemia. Anales del Sistema Sanitario de Navarra. 37(3). 429–434. 1 indexed citations
16.
Mendoza, Ander Estella‐Hermoso de, Remedios Castelló-Cros, Edurne Imbuluzqueta, et al.. (2014). Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia. Journal of Biomedical Nanotechnology. 11(4). 691–701. 17 indexed citations
17.
Agarwal, Anupriya, Raffaella Pippa, Christopher A. Eide, et al.. (2013). OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias. Blood. 122(21). 2511–2511.
18.
Pippa, Raffaella, Lluı́s Espinosa, Gunes Gundem, et al.. (2011). p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene. 31(38). 4207–4220. 66 indexed citations
19.
Domingo‐Domenech, Josep, et al.. (2007). Inactivation of NF-κB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. Breast Cancer Research and Treatment. 112(1). 53–62. 34 indexed citations
20.
Delaloye, B, et al.. (1980). Assessment of cortical function in children with malformations of kidneys and the urinary tract. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026